ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia

ClinicalTrials.gov ID: NCT03934099

Public ClinicalTrials.gov record NCT03934099. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 2:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-blind, Double-dummy, Parallel-group, Placebo and Active Comparator-controlled, Dose Finding, and Phase II Study to Assess Efficacy and Safety of LC350189 in Gout Patients With Hyperuricemia

Study identification

NCT ID
NCT03934099
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
LG Chem
Industry
Enrollment
156 participants

Conditions and interventions

Interventions

  • LC350189 formulated capsule Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2019
Primary completion
May 2, 2021
Completion
May 16, 2021
Last update posted
Dec 2, 2025

2019 – 2021

United States locations

U.S. sites
34
U.S. states
18
U.S. cities
31
Facility City State ZIP Site status
Synexus Clinical Research Birmingham Alabama 35211
Synexus Clinical Research Chandler Arizona 85224
Synexus Clinical Research Mesa Arizona 85206
Synexus Clinical Research Tucson Arizona 85712
Preferred Research Partner Little Rock Arkansas 72211
Health Awareness Inc Jupiter Florida 33458
Meridien Research Maitland Florida 32751
Miami Dade Medical Research Institute Miami Florida 33176
Meridien Research St. Petersburg Florida 33709
Clinical Research Trials of Florida, Inc Tampa Florida 33607
Avita Clinical Trials Tampa Florida 33613
IACT Health Columbus Georgia 31904
Synexus Clinical Research Chicago Illinois 60602
Synexus Clinical Research Richfield Minnesota 55423
Olive Branch Family Medical Cente Olive Branch Mississippi 38654
Synexus Clinical Research St Louis Missouri 63141
Quality Clinical Research Omaha Nebraska 68114
Synexus Clinical Research Omaha Nebraska 68144
Synexus Clinical Research Henderson Nevada 89052
OnSite Clinical Solutions Charlotte North Carolina 28226
OnSite Clinical Solutions Charlotte North Carolina 28277
Synexus Clinical Research Akron Ohio 44311
Synexus Clinical Research Cincinnati Ohio 45236
Synexus Clinical Research Columbus Ohio 43212
Paramount Medical Research and Consulting Middleburg Heights Ohio 44130
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
Synexus Clinical Research Anderson South Carolina 29621
Avant Research Associates Austin Texas 78704
Synexus Clinical Research Dallas Texas 75234
Discovery MM Services Incorporated Houston Texas 77450
Synexus Clinical Research San Antonio Texas 78229
Synexus Clinical Research Salt Lake City Utah 84123
Advanced Clinical Research West Jordan Utah 84088
Dominion Medical Associates Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03934099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 2, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03934099 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →